2018 Competition Deadline:  February 01, 2018

 

 

2018 Competition Guidelines

GUIDELINES:

Krescent 2018 Competition Guidelines 

APPLICATION FORMS:

Post-Doctoral Fellowship 

Post-Doctoral Fellowship Application

Condition of Eligibility Form

Appendix C

CV Module

Supervisory Experience Form

New Investigator Award

New Investigator Award Application

Condition of Eligibility Form

CV Module

 

  1. Introduction
  2. Eligibility
  3. Non-Employee Status
  4. KRESCENT Program Curriculum and Stipend
  5. Maximum Number of KRESCENT Program Fellowships Per Supervisor
  6. Indirect Costs
  7. Partnerships
  8. Competition Results
  9. Transfer of Awards
  10. Scientific Integrity and Scholarly Conduct
  11. Intellectual Property and Patents
  12. Use and Disclosure of Personal Information Provided to the KRESCENT Program
  13. Acknowledgment of KRESCENT Program Support
  14. Assessment of Information
  15. Forms of Publications and Variation by Discipline
  16. Contributions to Multi-Authored Papers
  17. Delays in Research and in Dissemination of Research Results
  18. Preparing Electronic Files
  19. Email Submission of Application

 

New for 2018: Patient review of the lay summary
The KRESCENT program is pleased to announce that patient partners will be adding their input to the peer review process for the 2018 KRESCENT competition. Patient partners will be asked to read and provide feedback on the lay summary that is provided by the applicant. They will be providing their feedback on the following criteria:

1. Clarity: is the lay summary easy to understand and written in appropriate language?
2. Relevance: are the study’s aims and issues addressed important to you as a patient?
3. Suggestions: for improvement for the future
4. Any additional comments to the applicant or questions for the peer review committee

Please pay particular attention to your lay summary as the patient partner feedback will be considered by the peer review committee and factored into your overall score.

In addition, if you have marked that your project has a patient-engagement component, patient partners will also provide feedback to Can-SOLVE CKD on this section (Section 1, page 3)

 

1. Introduction

Despite many scientific successes in kidney research over the last 45 years, Canadians are facing a growing epidemic of kidney disease due, in large part, to our aging population and the increasing number of people with diabetes, a leading cause of kidney disease.  Unfortunately, the dramatic rise in kidney disease has been accompanied by a relative decline in the number of well-trained kidney research scientists at academic centers in Canada. This is attributed to several factors, including the demands on clinician scientists to dedicate more time to the clinical care of patients.  Another factor is limitations in opportunities for salary support of those dedicated to research in general including in the field of kidney disease.

In response to the urgent need to better support the outstanding individuals who represent the future of kidney research in Canada, The Kidney Foundation of Canada, the Canadian Society of Nephrology, the CIHR Institutes of Nutrition, Metabolism and Diabetes (CIHR – INMD) and Circulatory and Respiratory Health (CIHR – ICRH) created an innovative new program to enrich the training and mentorship of new investigators.  The Kidney Research Scientist Core Education and National Training program (KRESCENT) represents a unique partnership destined to enhance research capacity by creating conditions that will foster the growth and development of Canada’s brightest research minds.

The objectives of the KRESCENT program are:

  • To enhance kidney research capacity by training increased numbers of highly skilled scientists, across multiple disciplines, focused on the prevention of end-stage renal disease and improving the health of Canadians with kidney disease.
  • To engage kidney researchers in the development of transdisciplinary kidney research networks.
  • To create sustainable momentum in supporting research careers of kidney scientists.

Application to the KRESCENT program is open to applicants, from all disciplines relevant to kidney disease (i.e. biomedical, clinical, health services and population health disciplines) in the following categories:

  • New Investigator Awards: Researchers, within the first three years of their first faculty appointment (assistant professor level or equivalent) at the time the Award commences, who have a MD and/or PhD New Investigator Awards must be held at Universities in Canada.
  • Post-Doctoral Fellowship: Includes MDs and Post-Doctoral PhDs.
  • Allied Health Doctoral Awards:  All applications for Allied Health Doctoral Awards must be submitted to The Kidney Foundation of Canada, deadline March 15, 2018 by 11:59 pm EST. Details regarding the application process for these awards can be found on the KFOC website (www.kidney.ca).  These applications will be reviewed by the KFOC Allied Health Scientific Committee. The KRESCENT Allied Health Doctoral Award will be awarded on the recommendation of the Allied Health Scientific Committee.

(For detailed eligibility criteria please see the eligibility section for the various programs)

top

2. Eligibility

Applicants must be Canadian citizens or permanent resident at the time of submission of their application.  

For New Investigator Awards, applicants must apply through a university department or affiliated institution offering the faculty appointment.

For Post-Doctoral Fellowship applicants must apply through a university department or affiliated institution that has been accepted as suitable for research training by the KRESCENT program. Institutions eligible to host a KRESCENT Fellow include Canadian and foreign universities, affiliated research hospitals, and colleges with a strong research mandate and capacity.

For Allied Health Doctoral Award eligibility criteria please consult the KFOC web site (www.kidney.ca)

 

top

3. Non-Employee Status

The granting of an award is deemed to establish neither an employer-employee relationship nor a partnership between the grantor and grantee.



top

4. KRESCENT Program Curriculum and Stipend

The KRESCENT program offers a competitive salary stipend (see Guidelines of individual awards for specific stipend levels).

Awardees will be required to participate and complete a core kidney research curriculum.  For detailed information on the curriculum see KRESCENT Curriculum document.



top

5. Maximum number of KRESCENT Program Fellowships Per Supervisor

The KRESCENT program will not fund more than two Fellowships per supervisor at one time.


top

6. Indirect Costs

The KRESCENT program funds only personnel and infrastructure support awards. No funding is provided for indirect costs of research (e.g. library, heat and light, office furniture, overhead, administrative charges and fees).



top 

7. Partnerships

Alberta Innovates
The KRESCENT program has recently partnershiped with Alberta Innovates (AI) to fund a KRESCENT Post-Doctoral or Allied Health Doctoral Fellowship. The purpose of the partnership is to increase the current funding available for excellent research training to build capacity in the kidney research field in Alberta. In order to be eligible for this award, the applicant must apply to and be successful in both the KRESCENT program and the Alberta Innovates general competition. The specific eligibility requirements for the KRESCENT and Alberta Innovates competitions can be found on their respective websites. (www.krescent.ca and www.aihealthsolutions.ca). 

The award amounts are listed below: 

  • Post-Doctoral Fellowships are awarded to highly qualified doctoral graduates for a maximum of three years. The stipend for those holding a PhD without a MD or equivalent degree is $55,000 per year plus a $5,000 career development allowance. The stipend for those holding an MD with or without a PhD degree is $75,000 per year plus a $5,000 career development allowance. 
  • Allied Health Doctoral Award/Graduate Studentships are awarded to highly qualified students enrolled in a thesis-based graduate program. The stipend for Allied Health Doctoral students is a maximum of $35,000 per plus a $2,000 career development allowance for a maximum of 3 years. 

Successful applicants to the program must acknowledge the combined funding support (Alberta Innovates and KRESCENT) in all publications and presentations for the duration of the program.

About Alberta Innovates:
Alberta Innovates is the province’s leading organization tasked with delivering on the research and innovation priorities of the Government of Alberta. Alberta Innovates’ role is to accelerate innovation in the province’s agriculture, energy, environment, forest and health sectors. In the health sector, Alberta Innovates provides leadership for Alberta’s health research and innovation enterprise by directing, coordinating, reviewing, funding and supporting health research and innovation. Working with its many partners in the health system, Alberta Innovates ensures that health research achieves innovation in care, policy and practice, and that the needs of patients and clinicians influence research.

 

Ontario Renal Network (ORN)
The KRESCENT program has entered into a partnership with the ORN to fund a KRESCENT award to further the goals of the ORN’s provincial renal strategy, currently the Ontario Renal Plan II. The purpose of this award is to increase the current funding available for excellent research training to promote a better understanding of the use of evidence in health decision- and policy-making. To be eligible for this award, the applicant must be working on a research project that aligns with the ORN. In addition, these projects must have a health policy focus, and the research must be related to the Ontario CKD population. The successful applicant will have the unique opportunity to attend certain ORN meetings, collaborate with ORN leadership and perform research that may have a direct impact on the provision of kidney care in Ontario.  

The Award amounts are listed below:

  • Post-Doctoral Fellowships are awarded to highly qualified doctoral graduates for a maximum of three years. The stipend for those holding a PhD without a MD or equivalent degree is $55,000 per year. The stipend for those holding an MD with or without a PhD degree is $65,000 per year.
  • New Investigator Awards are awarded to highly qualified doctoral graduates within 36 months of their first academic appointment, for a maximum of three years. The stipend for those holding a PhD without a MD or equivalent degree is $65,000 per year. The stipend for those holding an MD with or without a PhD degree is $70,000 per year. (New Investigators are also eligible to apply for the $25,000 infrastructure award.)

Successful applicants to the program must acknowledge the combined funding support (Ontario Renal Network and KRESCENT) in all publications and presentations for the duration of the program.

About the Ontario Renal Network (ORN):
The ORN is a division of CCO (an agency of the Government of Ontario), which manages the delivery of chronic kidney disease services. ORN’s decisions and advice are based on the best evidence available, enabling ORN to provide effective planning, programs and funding to support a continuously improving kidney care system in Ontario.  ORN is also responsible for establishing consistent standards and guidelines to support quality kidney care, and putting in place information systems to measure performance.  ORN is committed to ensuring care as close to home as possible while involving patients in system design and planning, and enabling patients and families to make informed decisions with their healthcare providers.

 

Can-SOLVE CKD Training program
Can-SOLVE CKD is a pan-Canadian patient-oriented kidney research network. In partnership with patients, researchers, health care providers and policy-makers, Can-SOLVE is working to transform treatment and care for Canadians living with or at risk for chronic kidney disease.  Can-SOLVE CKD is funded by the Canadian Institutes of Health Research and over 30 partners, including the Kidney Foundation of Canada, the Canadian Society of Nephrology, provincial kidney care agencies, universities, industry, and private donors.

Research projects that involve a significant component related to patient engagement and participation are eligible for inclusion in the Can-SOLVE training program. This program entails full participation in the KRESCENT curriculum, plus an additional Can-SOLVE CKD training component which includes completion of CIHR training modules and patient engagement exercises (approximately an additional 3.5 days per year. Expenses associated with participation/completion in these exercises will be covered by Can-SOLVE CKD.)

The Canadian Institutes of Health Research (CIHR) defines patient oriented research (POR) as “Patient-oriented research is about putting patients first. Research is informed by patients and focuses on what is important to patients. It produces information for decision makers and health care providers that will improve health care practices, therapies and policies. It ensures that new and innovative diagnostic and therapeutic approaches are applied where they are needed.”

In order to be eligible for the Can-SOLVE KRESCENT award, the patient engagement aspect must be well developed in your application (at the time of application). However, your research project does not have to be part of the Can-SOLVE CKD Network – any project with a significant focus in POR is eligible. Please note that applying to be a Can-SOLVE trainee will not in any way affect the peer review of your application. 


top

8. Competition Results

Successful applicants will be notified by an official letter before May 31 and the results will be posted on the Internet.



top

9. Transfer of Awards

Awardees may not change supervisors, projects or institutions without the written permission of the Chair of the Program Steering Committee.  The institution to which the awardee is moving will be required to supply the same supporting documentation as was required in the original application.



top

10. Scientific Integrity and Scholarly Conduct

Institutions receiving funds must have appropriate policies in place for investigating allegations of misconduct as outlined in “Integrity in Research and Scholarship: A Tri-Council Policy Statement” as published by the Canadian Institutes of Health Research (CIHR). Any questions concerning scientific integrity or scholarly conduct that arise during the course of the evaluation of an application will be referred back to the parent institution for that body to proceed with an enquiry. The KRESCENT program is to be informed of the outcome of such investigations.



top

11. Intellectual Property and Patents

The KRESCENT program must be informed of any commercial application arising from KRESCENT program-supported activity.

The KRESCENT program does not retain or claim any ownership of, or exploitation rights to, intellectual property developed under KRESCENT program funding. These are owned by the institution and/or the inventor.

Should the inventor decide to pursue commercialization of any results of the research funded by the KRESCENT program, he or she must disclose to their institution any potential intellectual property arising from the research; he or she and the institution must make every effort to obtain the greatest possible benefit to Canada from the resulting commercial activity.

The above requirement for disclosure is not intended to supersede any policy on disclosure that the institution might already have in place.



top 

12. Use and Disclosure of Personal Information Provided to the KRESCENT Program

All personal information collected by the KRESCENT program about applicants is used to review applications, to administer and monitor awards, to compile statistics and to promote and support kidney research in Canada. Consistent with these purposes, applicants should also expect that information collected by the KRESCENT program may be used in the following ways:

  • For peer-review purposes, applications are provided to the Peer Review Committee. Applications may also be transmitted to external reviewers. The KRESCENT program informs all reviewers of the obligation to maintain confidentiality and to protect the information entrusted to them.
  • Funding decisions – After peer review, merit scores, rank, project title and committee recommendations on budget and terms, will be made available to: program staff managing funding envelopes, the Program Steering Committee and Governing Council.
  • For the purposes of public information the KRESCENT program routinely publishes and disseminates certain details about successful award applications, including the name of the applicant, the amount awarded, the institution, the department, the title of the project and the summary of research prepared by the applicant for public release. For Post- Doctoral Fellowships and Allied Health Doctoral Awards the proposed location of tenure of the field of research may also be made public.
  • For administrative and planning purposes, the KRESCENT program uses files and databases containing personal information for program planning, evaluation, review and audits, and for general statistics for these activities. This information is also used to generate mailing lists for dissemination of the KRESCENT program publications and other information to the research community.
  • For purposes of equity, the KRESCENT program application forms ask for the gender of the applicant, but this is provided on voluntary basis only. This information is not used in the peer review process. It is used to promote the increased participation of women in the KRESCENT program and on KRESCENT program committees and to generate statistics pertaining to the program.

The KRESCENT program also collects data on the language capability of individuals for administrative and statistical purposes. The data are not used in the peer adjudication process.

Information submitted to the KRESCENT program is subject to the “Tri-Council Policy: Integrity in Research and Scholarships” and may be used and disclosed consistent with that policy.


top 

13. Acknowledgment of KRESCENT Program Support

Awardees are expected to acknowledge the KRESCENT program’s financial support in a standardized fashion:  in publications arising from the supported research, in conference or congress material, and on equipment and facilities purchased and/or developed with the Program’s funds.

The KRESCENT program expects that all those who receive support will accept invitations from The Kidney Foundation of Canada and other professional and scholarly associations (e.g. CANNT, CANSW, AND) to present their research at meetings or conferences.

KRESCENT awardees are expected to attend the annual scientific meeting of the Canadian Society of Nephrology and submit abstracts to this meeting.



top 

14. Assessment of Information

The KRESCENT program advises its peer review committee that the quality of a publication’s content is the determining factor in their assessment of productivity and performance.  The committee is asked NOT to rely on the number of publications nor, in the case of journals, to use lists of “prestigious” or “unacceptable” journals.

 

15. Forms of Publications and Variation by Discipline

The KRESCENT program funds researchers in many health related areas and is aware that forms of research publications vary among disciplines. Some disciplines publish almost exclusively in peer-reviewed books, while others favour refereed journals.  There is much variation between and within disciplines.  The Program advises its peer review committee to evaluate according to the standards of the discipline.


top 

16. Contributions to Multi-Authored Papers

Publications are often prepared jointly with students, (Post-) Doctoral fellows, other researchers, etc. Applicants should describe their intellectual contribution to collaborative work or joint publications in their application, where indicated.



top 

17. Delays in Research and in Dissemination of Research Results

The KRESCENT program recognizes that research productivity may vary as result of personal circumstances, or during periods of pregnancy or early childcare, whether or not formal leave of absence is taken.  Administrative leave, disability, elder care, and other situations may also result in publication delays.

Applicants should clearly and fully describe in their application any circumstances that have or will affect the research productivity or dissemination of research results.  The KRESCENT program advises its peer review committee to be sensitive to the impact of these circumstances on the level of productivity, while ensuring that the quality of the research remains competitive. Each case is reviewed on its own merits.




top 

18. Preparing Electronic Files

Preparation of Post-Doctoral Fellowship files

Preparation of New Investigator Award files



top 

19. Email Submission of Application

Please see individual awards for deadlines and requirements before submitting your application.

The applicant must submit a PDF copy of the full application (including all addenda and signatures) by email to chris.marquis@kidney.ca no later than February 01, 2017 by 11:59 pm EST.

Applications can only be submitted by email.

 

For information on the KRESCENT program, please contact:


Elisabeth Fowler
National Director of Research
The Kidney Foundation of Canada
Tel.:    1-888-210-9894, ext. 104
Email: elisabeth.fowler@kidney.ca

 

For further information on application submissions, please contact:

 

Christine Marquis
Associate, Research Grants and Awards
The Kidney Foundation of Canada
Telephone: (514) 369–4806, ext. 232
E-mail: chris.marquis@kidney.ca

The KRESCENT Program is a Strategic Training Program developed and supported by:

                                                    


With additional generous support from:

AMGEN               Baxter Corporation               Merck-Frosst Canada Ltd.             Ortho Biotech              RocheShire BioChem Inc.

© 2005 The Kidney Foundation of Canada